Korsana Biosciences KRSA
NASDAQ KRSA
$33.43 +0.89 (+2.74%)
At close: Oct 22, 2026 · 4:00 PM EDT

Korsana Biosciences (KRSA) Total Non-Current Liabilities (2019)

Updated

Korsana Biosciences (KRSA) recorded Total Non-Current Liabilities of $17.47 million in Q1 2019.

Analysis

Korsana Biosciences (KRSA) Total Non-Current Liabilities (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 102.65 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 106.45 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 33.91 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 35.10 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 97.04 Bn
10 Korsana Biosciences 15.41 Mn 954,428.44 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 17.47 Mn
API Access

Korsana Biosciences Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=KRSA&period=max&api_key=YOUR_API_KEY